As someone working in this area, this is an interesting article.
The core issue of compliance is somewhat buried in the text, but worth pointing out. Optometrists' chief complaint is that very few offices seem to be prescribing the Hubble contacts brand specifically and yet, Hubble seem to be selling them to customers. This implies to them that either all prescriptions aren't being verified or are somehow being "passively" verified. Within the current rules set in place by the FTC, they believe it's unlikely quite so many prescriptions are passively verified.
The FTC is actually actively working on developing new rules around prescription verification to address some of these concerns. [1]
The core issue of compliance is somewhat buried in the text, but worth pointing out. Optometrists' chief complaint is that very few offices seem to be prescribing the Hubble contacts brand specifically and yet, Hubble seem to be selling them to customers. This implies to them that either all prescriptions aren't being verified or are somehow being "passively" verified. Within the current rules set in place by the FTC, they believe it's unlikely quite so many prescriptions are passively verified.
The FTC is actually actively working on developing new rules around prescription verification to address some of these concerns. [1]
[1]: https://www.ftc.gov/news-events/press-releases/2019/05/ftc-s...